The global alpha 2C adrenergic receptor market is anticipated to grow at a significant CAGR during the forecast period. The alpha 2C adrenergic receptor is a G protein-coupled receptor (GPCR). It is associated with the Gi heterotrimeric G-protein. The major factor accelerating the growth of the market is the increasing prevalence of bipolar disorder across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/alpha-2c-adrenergic-receptor-market
According to the National Institute of Mental Health (NIMH), bipolar disorder affects approximately 5.7 million adults or about 2.6% of the population age 18 and older every year in the US. Additionally, the median age for bipolar disorder is 25 years, however, the illness can also start in early childhood or as late as 40-50 years of age. Further, as per the World Health Organization (WHO), epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Hence, the rising prevalence of bipolar disorder is increasing the demand for alpha 2C adrenergic receptors.
Some major players in the market include Johnson & Johnson Services, Inc., and Otsuka Holdings Co Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2021, Otsuka Pharmaceutical Co., Ltd. announced the regulatory approval of REXULTI (brexpiprazole), an orally disintegrating dose (OD) tablet in Japan. Brexpiprazole is a serotonin-dopamine activity modulator (SDAM). It acts as a partial agonist at 5-HT1A and dopamine D2 receptors and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Johnson & Johnson Services, Inc., and Otsuka Holdings Co Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Alpha 2C Adrenergic Receptor Market Report by Segment
By Type
- Lacripep
- JNJ-4789
- SKL-PSY
- Others
By Application
- Bipolar Disorder
- Dry Eye
- Major Depressive Disorder
- Others
A full report of Alpha 2C Adrenergic Receptor Market is available at: https://www.omrglobal.com/industry-reports/alpha-2c-adrenergic-receptor-market
Alpha 2C Adrenergic Receptor Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Johnson & Johnson Services, Inc.
- Otsuka Holdings Co Ltd.
